LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Construction & Landscaping Businesses for Sale
Dollar Stores for Sale
Entertainment & Recreation Businesses for Sale
Digital Marketing Business for Sale
Coffee Shop, Bakery & Dessert Businesses for Sale
Transport & Shipping Businesses for Sale
Childcare & Educational Businesses for Sale
Cleaning & Janitorial Businesses for Sale
Pet Businesses for Sale
Hotels and Motels for Sale
Senior Care Franchise for Sale
Miscellaneous Franchises for Sale
Home Based Franchise Opportunities
Wholesale & Distribution Franchise Opportunities
Consultancy & Training Franchise Opportunities
Finance & Accounting Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Liquor Franchises for Sale
Cleaning & Janitorial Franchises for Sale
Fitness & Wellness Franchises for Sale
Office Buildings for Sale or Rent
Warehouses for Sale or Lease
Medical Buildings for Sale or Lease
Places of Worship for Sale
Retail Buildings for Sale or Lease
Office Spaces for Sale or Rent
Apartment Buildings for Sale
Commercial Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
Medical Office Spaces for Sale or Rent
An email will be sent to registered email address.
Please select if you are: